Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...
axiom P : Nat → Prop axiom P.intro : P n inductive AckFuel : (n m : Nat) → Type where | step1 : AckFuel 0 m | step2 : AckFuel n 1 → AckFuel (n + 1) 0 | step3 : (∀ m', P m' → AckFuel n m') → AckFuel (n ...
Today, a brief rundown of news involving Insmed and Recursion Pharmaceuticals, as well as updates from Odyssey Therapeutics, Gilead Sciences and Novo Nordisk that you may have missed. Against the ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
Wild orangutans use multi-layered recursive vocal patterns that vary with danger, challenging the idea that only humans use complex, structured communication. In a groundbreaking study from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback